Friedrich, Maximilian U. http://orcid.org/0000-0002-3695-1268
Schneider, Erich
Buerklein, Miriam
Taeger, Johannes
Hartig, Johannes
Volkmann, Jens
Peach, Robert
Zeller, Daniel
Funding for this research was provided by:
IZKF Wuerzburg (Z2-CSP13, AdvCSP-4)
Deutsche Forschungsgemeinschaft (Project-ID 424778381, TRR 295)
Universitätsklinikum Würzburg
Article History
Received: 8 September 2022
Revised: 14 November 2022
Accepted: 16 November 2022
First Online: 23 November 2022
Declarations
:
: MF, JH, MB, JT, and RP report no conflicts of interest. JV reports grants and personal fees from Medtronic Inc., grants and personal fees from Boston Scientific, personal fees from St. Jude, outside the submitted work. ES is the developer of EyeSeeCam and CEO of EyeSeeTec. DZ received compensation for scientific consultancy from Novartis, for advisory boards from Biogen, and for training activities from Desitin, outside the submitted work.
: Subjects gave informed written consent to participate in the study which was conducted under the Julius-Maximilians University Wuerzburg’s ethics committee approval #318/21. Patients gave informed written consent to storage, analysis, sharing and publication of their clinical data, including consent to disclose potentially identifiable information and material (i.e., videos, photos) for scientific publication.